Transcatheter Aortic Valve Replacement (TAVR) in Patients with Paradoxical Low-Flow Low-Gradient Aortic Stenosis
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier BV in Structural Heart
- Vol. 4 (4), 312-319
- https://doi.org/10.1080/24748706.2020.1764155
Abstract
Background Aortic valve replacement is recommended in symptomatic patients with severe aortic stenosis (AS) or asymptomatic with reduced left ventricular ejection fraction (LVEF). The treatment algorithm of patients with paradoxical low-flow (pLF-LG) AS is not well defined. The purpose of this study is to examine the efficacy and outcomes of TAVR in patients with pLF-LG AS at our institution. Methods From 2008 to 2017, we retrospectively analyzed patients who underwent TAVR with an LVEF > 50% and stratified into 4 groups based on gradient and stroke volume index. The groups were normal flow, high gradient (NFHG), normal flow, low gradient (NFLG), low flow, high gradient (LFHG), and paradoxical low flow, low gradient (pLF-LG). Baseline, procedural characteristics, post-procedure, 30-day and 12-month endpoints were obtained. Our primary endpoints included all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE) a) at post-procedure, 30-days, and 1-year. Results Groups were NF-HG (n=145), NF-LG (n=81), LF-HG (n=97), and pLF-LG (n=75). There was increased prevalence of pacemakers in the pLF-LG group (p=0.01) and a significant difference in the prevalence of atrial fibrillation (AF) (p=0.01). No difference in post-procedure, 30-day, and 12-month all-cause mortality and MACCE was noted. All patients demonstrated symptomatic improvement as measured by New York Heart Association (NYHA) class at 30-days and 12-months (pConclusion When compared to patients with normal flow and high gradients, patients with pLF-LG treated with TAVR had similar procedural complications and 30-day and 1-year mortality with improvement in symptom profile. Once identified as symptomatic, patients with pLF-LG should undergo valve replacement.Keywords
Funding Information
- Doris Duke Charitable Foundation (2014106)
This publication has 24 references indexed in Scilit:
- Impact of Low Flow on the Outcome of High-Risk Patients Undergoing Transcatheter Aortic Valve ReplacementJournal of the American College of Cardiology, 2013
- Predictors of Mortality and Outcomes of Therapy in Low-Flow Severe Aortic StenosisCirculation, 2013
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2)European Journal of Cardio-Thoracic Surgery, 2012
- Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve ImplantationJournal of the American College of Cardiology, 2012
- Low-Gradient Aortic Valve Stenosis: Myocardial Fibrosis and Its Influence on Function and OutcomeJournal of the American College of Cardiology, 2011
- Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection FractionCirculation, 2011
- Assessment of aortic stenosis severity: when the gradient does not fit with the valve areaHeart, 2010
- Low-Flow, Low-Gradient, Normal Ejection Fraction Aortic StenosisCurrent Cardiology Reports, 2010
- Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatmentEuropean Heart Journal, 2009
- Paradoxical Low-Flow, Low-Gradient Severe Aortic Stenosis Despite Preserved Ejection Fraction Is Associated With Higher Afterload and Reduced SurvivalCirculation, 2007